FALCON
Live / Applied — First extension granted (statement of use) (as of 17 May 2025)
What this means for you
Not registered yet, but its 07 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97063853
- Mark type
- Stylized text
- Filed
- 07 Oct 2021
- Published for opposition
- 24 Sept 2024
- Attorney of record
- GREGORY J. CHINLUND
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, drug formulations for use in neurological and central nervous system treatment regimens
- Class 010 — Medical apparatus: Drug delivery system comprised of catheters, needles, ports, and infusion pumps; medical device for administering drugs for treatment of neurological and central nervous system disorders
Owner
- NEELA THERAPEUTICS, INC., LUNENBURG, MA, US
- Alcyone Therapeutics, Inc., Lowell, MA, US
- Alcyone Therapeutics, Inc., Lowell, MA, US
Prosecution history
- 04 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2025 — SOU EXTENSION 1 GRANTED
- 16 May 2025 — SOU EXTENSION 1 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2024 — EXPARTE APPEAL TERMINATED
- 15 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Dec 2023 — LETTER OF SUSPENSION E-MAILED
- 15 Dec 2023 — SUSPENSION LETTER WRITTEN